EBS
Emergent Biosolutions Inc
6.80$
-3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -60.4% | +20.3% | +289.1% | -79.9% | +349.8% | +185.6% | -40.2% | -110.6% | – | – | +190.6% | |
| – | +8.9% | +8.2% | +11.4% | +46.1% | +78.0% | +3.4% | +8.1% | +15.8% | -12.7% | -13.0% | -11.9% | |
| – | +23.5% | +16.6% | -17.7% | +52.5% | +15.1% | +94.0% | -18.1% | +6.4% | -48.8% | -22.1% | -10.0% | |
| – | -18.0% | -60.8% | +227.5% | +23.1% | +72.8% | +67.4% | +14.0% | -64.8% | – | – | – | |
| – | -586.7% | – | – | -321.7% | – | – | -1,746.3% | – | – | – | -125.3% | |
| – | +46.1% | +70.2% | -28.1% | +31.5% | +20.5% | +63.3% | +58.6% | -48.5% | -55.4% | -55.6% | -39.7% | |
| – | -78.4% | +67.7% | +227.7% | +259.0% | -89.2% | +56.8% | +48.1% | +69.5% | – | -41.0% | -44.6% | |
| – | -100.0% | – | – | – | – | +2,125.0% | -10.7% | – | – | – | – | |
| – | -50.0% | +1,000.0% | +2,909.1% | -99.7% | +7,300.0% | +86.5% | +668.1% | -22.5% | +0.0% | – | -202.9% | |
| – | -98.9% | -1,100.0% | +12.3% | – | -98.3% | +297.8% | -165.9% | – | -196.3% | -63.5% | -45.2% | |
| – | -83.2% | -155.7% | +175.7% | – | -104.6% | – | -302.9% | – | -211.3% | -64.5% | -28.1% | |
| – | -68.1% | -227.8% | – | – | – | +715.6% | -110.0% | – | -900.8% | – | – | |
| – | -100.4% | – | – | -119.8% | – | +290.7% | -75.7% | -256.0% | – | – | +338.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.